Shell Announces Final Investment Decision for Major Brazil Oil Field, Set for 120,000 Barrels/Day
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 21 2025
0mins
Source: Benzinga
Shell's Gato do Mato Project: Shell Brasil Petróleo Ltda. has made the Final Investment Decision for the Gato do Mato project in Brazil, aiming to produce up to 120,000 barrels of oil per day with an estimated recoverable resource of 370 million barrels, expected to begin operations in 2029.
Market Impact: Shell's stock (SHEL) is currently down 0.58% at $71.53, reflecting investor sentiment amidst ongoing developments in their production capabilities and strategic initiatives.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SHEL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SHEL
Wall Street analysts forecast SHEL stock price to fall
10 Analyst Rating
5 Buy
5 Hold
0 Sell
Moderate Buy
Current: 85.660
Low
41.75
Averages
74.27
High
91.00
Current: 85.660
Low
41.75
Averages
74.27
High
91.00
About SHEL
Shell plc is an international energy company engaged in the principal aspects of the energy and petrochemical industries. The Company's segments include Integrated Gas, Upstream, Marketing, Chemicals and Products, Renewables and Energy Solutions, and Corporate. The Integrated Gas segment includes liquefied natural gas (LNG), conversion of natural gas into gas-to-liquids (GTL) fuels and other products. It includes natural gas and liquids exploration and extraction, and the operation of the upstream and midstream infrastructure. The Upstream segment includes exploration and extraction of crude oil, natural gas and natural gas liquids. It also markets and transports oil and gas and operates the infrastructure necessary to deliver them to the market. The Marketing segment comprises the Mobility, Lubricants, and Sectors & Decarbonization businesses. The Chemicals and Products segment include chemical manufacturing plants with their own marketing network, and refineries.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Stock Price Fluctuation: AVDE's 52-week low is $72.08 and high is $92.60, with the last trade at $90.89, indicating the stock is nearing its high point, potentially attracting investor interest.
- Technical Analysis Tool: Comparing the current stock price to the 200-day moving average can provide valuable insights for investors, aiding in market trend assessment.
- ETF Trading Mechanism: ETFs trade like stocks, where investors buy and sell 'units' that can be created or destroyed based on demand, impacting liquidity and market dynamics.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding for ETFs highlights significant inflows (new units created) or outflows (old units destroyed), which can affect the underlying holdings and overall market performance.
See More
- AbbVie's Dividend King Status: AbbVie has increased its dividend for 54 consecutive years, boasting a dividend yield exceeding 3%, with seven of its twelve blockbuster drugs generating over $2 billion annually, indicating strong growth potential that is likely to drive stock price appreciation.
- Chevron's Stable Returns: Chevron has raised its dividend for 39 years, currently yielding 3.8%, and can sustain dividends and capital expenditures even if oil prices fall below $50 per barrel, showcasing robust financial resilience and attractiveness to investors.
- Enterprise Products' High Yield: Enterprise Products Partners offers a distribution yield of 5.8% and has increased its distribution for 27 consecutive years, with a strong balance sheet and 90% of long-term contracts insulated from inflation, positioning it favorably in the energy market.
- Market Volatility and Investment Opportunities: While the likelihood of rate cuts remains low due to rising inflation and a strong job market, this dynamic makes stable income investments more appealing, with high-dividend stocks like AbbVie, Chevron, and Enterprise Products becoming top picks for investors.
See More
- AbbVie's Strong Growth: AbbVie markets 12 blockbuster drugs, with 7 generating over $2 billion in annual sales, and boasts a 54-year streak of dividend increases, currently yielding 3%, positioning it strongly in the pharmaceutical sector.
- Chevron's Stable Returns: Chevron has increased its dividend for 39 consecutive years, with a current yield of 3.8%, and has repurchased shares in 18 of the last 22 years, demonstrating a strong commitment to shareholder returns, with expected annual EPS growth of over 10%.
- High Yield from Enterprise Products: Enterprise Products Partners offers a distribution yield of 5.8% and has increased distributions for 27 consecutive years, supported by a strong balance sheet and high credit rating, indicating continued growth potential.
- Market Environment Impact: With rising inflation and a strong job market, increased market volatility may occur, yet high-yield stocks like AbbVie, Chevron, and Enterprise Products are likely to attract income-seeking investors, potentially driving their stock prices higher.
See More
- Dividend Payment Details: Shell has announced a first quarter 2026 dividend of $0.3906 per share, €0.3381, or 29.18p, reflecting the company's ongoing profitability and commitment to shareholder returns.
- Multi-Currency Options: Shareholders can elect to receive dividends in USD, EUR, or GBP by June 8, 2026, enhancing shareholder satisfaction and potentially attracting more investors due to this flexibility.
- Payment Schedule: The dividend will be paid on June 29, 2026, ensuring that shareholders registered by May 22, 2026, receive timely returns, which underscores the company's commitment to shareholder rights.
- Tax Advisory Note: The announcement advises shareholders to consult tax advisors regarding dividend tax treatment, reflecting the company's emphasis on compliance and transparency to mitigate potential legal risks.
See More
- Significant Revenue Decline: C3.ai reported $250.3 million in revenue for fiscal 2026, reflecting a 35% year-over-year decline, indicating severe challenges in customer acquisition and retention that undermine its market competitiveness.
- Escalating Losses: The company incurred a net loss of $470.4 million in fiscal 2026, a 63% increase from the previous year's losses, forcing C3.ai to cut approximately 35% of its workforce to mitigate financial strain.
- Pessimistic Future Revenue Outlook: Management forecasts revenue between $210 million and $240 million for fiscal 2027, suggesting a year-over-year decline even at the upper end, highlighting significant hurdles in returning to growth.
- Stock Valuation Appears Cheap: While C3.ai's price-to-sales ratio stands at 6.1, below the five-year average of 10.5, the forward P/S ratio rises to 6.9 due to declining revenue expectations, indicating that investors should approach the stock with caution despite its falling price.
See More
- Management Disruption Impact: C3.ai's founder Thomas Siebel stepped down as CEO last year due to health issues, leading to a sharp decline in sales, highlighting the significant impact of management changes on business operations.
- Revenue Decline: C3.ai generated $250.3 million in revenue for fiscal 2026, a staggering 35% drop year-over-year, while the company reported a net loss of $470.4 million, which is 63% higher than the previous year's loss, indicating severe financial challenges.
- Layoffs and Restructuring: In response to declining revenues, C3.ai cut approximately 35% of its workforce, which may help reduce costs but could also limit the company's growth potential, with management forecasting revenues to further decline to between $210 million and $240 million in fiscal 2027.
- Valuation and Investment Risks: C3.ai's current price-to-sales ratio stands at 6.1, below its five-year average of 10.5, making it appear cheap; however, with future revenue expectations declining, its forward P/S ratio rises to 6.9, prompting investors to carefully assess its long-term investment value.
See More











